Prophylactic Administration of Levosimendan in Patients With Impaired Left Ventricular Function Undergoing Coronary Surgery.
Phase of Trial: Phase IV
Latest Information Update: 08 May 2014
At a glance
- Drugs Levosimendan (Primary)
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- 11 Mar 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 27 Nov 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Nov 2013 Planned end date changed from 1 Apr 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.